FITZGERALD MEGHAN sold 31.8% of their position (20K shares) of ROIVANT SCIENCES LTD. on the open market
Open‑market sale worth $798.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/11/2026ACC: 0001140361-26-036246
-20K
Net shares
Net seller
$798.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20K acquired · 40K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+20K
Price / share
$8.80
Trade value
$176K
% of position
46.6%
9/8/2026
42.96K→62.96K
Common Shares
Direct
Shares
−20K
Price / share
$39.90
Trade value
$798K
% of position
31.8%
9/8/2026
62.96K→42.96K
Total
Net shares
+0.00
Net value
-$622K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/8/2026 | M · Option Exercise | +20K | $8.80 | $176K | 46.6% | 42.96K | 62.96K |
| Common Shares Direct | 9/8/2026 | S · Sale | −20K | $39.90 | $798K | 31.8% | 62.96K | 42.96K |
| Total | +0.00 | -$622K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
20K shares
Shares
−20K
Strike price
8.8
Held after
18.58K
Exercisable
—
9/8/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock20K shares | 9/8/2026 | M · Option Exercise | −20K | 8.8 | — | 18.58K |